From: owner-finbionet-members@helsinki.fi owner-finbionet-members@helsinki.fi On Behalf Of Tienhaara, Anita M H Sent: 31. elokuutata 2020 15:12 To: finbionet-members@helsinki.fi Subject: The HiLIFE - Institute of Biotechnology, University of Helsinki, Varjosalo laboratory of Molecular Systems Biology / Pathology, invites applications for a postdoctoral researcher

The University of Helsinki, founded in 1640, is one of the world's leading universities for multidisciplinary research. The university has an international academic community of 40,000 students and staff members. The University of Helsinki offers comprehensive services to its employees, including occupational health care and health insurance, sports facilities, and professional development opportunities. The International Staff Services office assists employees from abroad with their transition to work and life in Finland.

The HiLIFE - Institute of Biotechnology is a research institute that operates at the highest international level. It includes 40 research groups and 250 researchers. The Institute is situated in the Viikki science park. For more information on the Institute, please visit (https://www.helsinki.fi/en/hilife-institute-of-biotechnology).

The HiLIFE - Institute of Biotechnology, Varjosalo laboratory of Molecular Systems Biology / Pathology, invites applications for a

POSTDOCTORAL RESEARCHER

The Varjosalo lab has a longstanding interest in the global and comprehensive understanding of how key cellular signaling molecules; protein kinases, protein phosphatases and transcription factors mediate their signaling potential and how the signaling is changed in diseases in the immunology and oncology axis, and more recently Covid-19. For this purpose, we have developed experimental and computational methods to identify the protein-interactions formed by these signaling molecules. Additionally, we employ quantitative mass spectrometry -based proteomics to assess the protein abundance changes, as well as phosphorylation status of the tissues/cells. Furthermore, combining the data from the different sets of 'omics' data (proteomics, HTS and HiSeq), allows us to generate global and systems level understanding on how disease-causing mutations mediate their effects, also enabling the development of therapeutic or diagnostic approaches.

We are seeking a post doc that has extensive practical experience in standard biochemistry/molecular biology/cell biological methods, ideally encompassing proteomics and microscopic techniques and/or bioinformatics. The ideal candidate is an adaptable team-player with excellent communication skills, both oral and written, and good organizational skills. More information and how to apply at https://www.helsinki.fi/en/open-positions/postdoctoral-researcher-varjosalo-...

Deadline for applications is September 25, 2020.